284 related articles for article (PubMed ID: 17290405)
1. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
Nielsen BS; Rank F; Illemann M; Lund LR; Danø K
Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405
[TBL] [Abstract][Full Text] [Related]
2. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
3. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
Nielsen BS; Sehested M; Timshel S; Pyke C; Danø K
Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179
[TBL] [Abstract][Full Text] [Related]
4. Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells.
Schnack Nielsen B; Rank F; Engelholm LH; Holm A; Danø K; Behrendt N
Int J Cancer; 2002 Apr; 98(5):656-64. PubMed ID: 11920633
[TBL] [Abstract][Full Text] [Related]
5. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator system localization in 60 cases of ductal carcinoma in situ.
Hurd TC; Sait S; Kohga S; Winston J; Martinick M; Saxena R; Lankes H; Markus G; Harvey S; Gibbs JF
Ann Surg Oncol; 2007 Nov; 14(11):3117-24. PubMed ID: 17701256
[TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer.
Nielsen BS; Sehested M; Duun S; Rank F; Timshel S; Rygaard J; Johnsen M; Danø K
Lab Invest; 2001 Nov; 81(11):1485-501. PubMed ID: 11706057
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.
Dublin E; Hanby A; Patel NK; Liebman R; Barnes D
Am J Pathol; 2000 Oct; 157(4):1219-27. PubMed ID: 11021826
[TBL] [Abstract][Full Text] [Related]
10. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
[TBL] [Abstract][Full Text] [Related]
11. Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization.
Hildenbrand R; Leitz M; Magdolen V; Luther T; Albrecht S; Graeff H; Stutte HJ; Bleyl U; Schmitt M
Histopathology; 2000 Jun; 36(6):499-504. PubMed ID: 10849091
[TBL] [Abstract][Full Text] [Related]
12. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ.
Sameni M; Cavallo-Medved D; Franco OE; Chalasani A; Ji K; Aggarwal N; Anbalagan A; Chen X; Mattingly RR; Hayward SW; Sloane BF
Breast Cancer Res; 2017 May; 19(1):56. PubMed ID: 28506312
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
[TBL] [Abstract][Full Text] [Related]
14. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
[TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue.
Hildenbrand R; Wolf G; Böhme B; Bleyl U; Steinborn A
J Leukoc Biol; 1999 Jul; 66(1):40-9. PubMed ID: 10410988
[TBL] [Abstract][Full Text] [Related]
16. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.
Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J
J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
Jedeszko C; Victor BC; Podgorski I; Sloane BF
Cancer Res; 2009 Dec; 69(23):9148-55. PubMed ID: 19920187
[TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
[TBL] [Abstract][Full Text] [Related]
19. In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.
Sordat I; Chaubert P; Protiva P; Guillou L; Mazzucchelli L; Saraga E; Benhattar J; Trân-Thang C; Blum AL; Dorta G; Sordat B
Am J Pathol; 1997 Jan; 150(1):283-95. PubMed ID: 9006343
[TBL] [Abstract][Full Text] [Related]
20. Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion.
Rømer J; Pyke C; Lund LR; Eriksen J; Kristensen P; Rønne E; Høyer-Hansen G; Danø K; Brünner N
Int J Cancer; 1994 May; 57(4):553-60. PubMed ID: 8181859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]